Insmed Inc (INSM)
24.91
-0.90
(-3.49%)
USD |
NASDAQ |
Apr 25, 16:00
24.91
0.00 (0.00%)
After-Hours: 20:00
Insmed Accounts Payable (Quarterly): 65.39M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 65.39M |
September 30, 2023 | 65.38M |
June 30, 2023 | 55.70M |
March 31, 2023 | 56.67M |
December 31, 2022 | 50.46M |
September 30, 2022 | 11.58M |
June 30, 2022 | 31.14M |
March 31, 2022 | 48.57M |
December 31, 2021 | 35.78M |
September 30, 2021 | 23.53M |
June 30, 2021 | 31.08M |
March 31, 2021 | 22.42M |
December 31, 2020 | 42.85M |
September 30, 2020 | 22.15M |
June 30, 2020 | 25.00M |
March 31, 2020 | 18.19M |
December 31, 2019 | 13.18M |
September 30, 2019 | 20.42M |
June 30, 2019 | 17.03M |
March 31, 2019 | 30.22M |
December 31, 2018 | 17.74M |
September 30, 2018 | 16.58M |
June 30, 2018 | 15.97M |
March 31, 2018 | 13.18M |
December 31, 2017 | 14.67M |
Date | Value |
---|---|
September 30, 2017 | 9.348M |
June 30, 2017 | 11.03M |
March 31, 2017 | 8.454M |
December 31, 2016 | 10.44M |
September 30, 2016 | 8.283M |
June 30, 2016 | 9.402M |
March 31, 2016 | 8.688M |
December 31, 2015 | 7.468M |
September 30, 2015 | 10.86M |
June 30, 2015 | 8.681M |
March 31, 2015 | 7.86M |
December 31, 2014 | 9.249M |
September 30, 2014 | 8.867M |
June 30, 2014 | 11.41M |
March 31, 2014 | 9.818M |
December 31, 2013 | 5.929M |
September 30, 2013 | 4.661M |
June 30, 2013 | 7.865M |
March 31, 2013 | 8.184M |
December 31, 2012 | 7.06M |
September 30, 2012 | 2.985M |
June 30, 2012 | 3.198M |
March 31, 2012 | 2.879M |
December 31, 2011 | 2.334M |
September 30, 2011 | 1.504M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
11.58M
Minimum
Sep 2022
65.39M
Maximum
Dec 2023
34.55M
Average
31.08M
Median
Jun 2021
Accounts Payable (Quarterly) Benchmarks
NeuroMetrix Inc | 0.2155M |
Intra-Cellular Therapies Inc | 11.45M |
Rhythm Pharmaceuticals Inc | 4.885M |
Amylyx Pharmaceuticals Inc | 22.06M |
AN2 Therapeutics Inc | 2.676M |